Israeli Companies Collaborate to ‘Print’ Human Tissue Through Stem-Cell Inkjet Technology
Two Israeli companies have collaborated to create 3D printer ink that can form human tissue from stem cells, Israel21c reported on Tuesday.
Nano Dimension and Accellta joined forces to produce the special inkjet technology.
“We’re the first to do it really fast and really accurately, said Amit Dror, CEO of Nano Dimension. While acknowledging that his company is not the first to offer biotech printing, he explained, “We showed how the same thing can be achieved in a few seconds. That means this could eventually go into commercial use,” for example at a hospital during emergency surgery.
The 3D printer ink forms into human tissue when expelled through over 1,000 tiny nozzles of Nano Dimension’s DragonFly 3D printer. Nano Dimension’s main business revolves around printed circuit boards (PCBs)used in everyday items, such as cell phones. Dror said he often turns down offers from potential partners to collaborate on projects unrelated to PCBs, but not in this case.
The current collaboration came about when Accellta CEO Itzchak Angel told Dror that his company was good at creating and reproducing stem cells, but didn’t have the technology to turn the cells into tissue.
“For that we need a printer,” he said.
Nano Dimensions and Accellta worked together for several months to create the 3D printer ink, according to Israel21c. Dror said the delicate process involves making sure the stem cells are not electrified and killed when they are dispensed by the inkjet.
Nano Dimension applied for a patent, and the company’s stock price went up 17 percent the day it announced its collaboration with Accellta, Israel21c reported.